Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) was founded in May 2018, with its headquarters located in Foster City, California, USA. As of May 31, 2019, the company had 24 full-time employees. Mirum Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing late-stage pipeline products for new therapies aimed at alleviating liver diseases. The company focuses on diseases with high unmet medical needs where the biological principles of treatment are well-defined. Mirum Pharmaceuticals' product pipeline consists of two clinical-stage candidates with potential mechanisms of action that could be broadly applicable to orphan liver diseases.